논문KCI 등재
Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (3)
- Halil Haldun Emiroglu, "Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”", Clinical and Molecular Hepatology, 29(3), pp.812~812 (2023), 대한간학회
- Terrault NA, "Update on prevention, diagnosis, and treatment of chronic hepatitis B : AASLD 2018 hepatitis B guidance", Hepatology, 67, pp.1560~1599 (2018)
- Dutta A, "Variability in the upper limit of normal for serum alanine aminotransferase levels : a statewide study", Hepatology, 50, pp.1957~1962 (2009)
관련 논문AI추천
Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”Halil Haldun Emiroglu대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”Jeong-Ju Yoo, Sang Gyune Kim대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”Chia-Ming Chu, Yun-Fan Liaw대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?Dong Hyun Sinn, Joo Hyun Oh대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Correspondence to letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”Gi-Ae Kim, Seung Won Choi, Young-Suk Lim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Letter regarding “Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation”Yun-Fan Liaw대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제2호
이 간행물의 다른 논문 (26건)
Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer AssociationHyunchul Rhim, 김경민, Jin Woo Choi, Hee Ho Chu, Jung Suk Oh, In Joon Lee, Dong Hyeon Lee, Byung Chan Lee, Yuri Cho, Han Ah Lee, Dongho Hyun, Hoon Kwon, Kun Yung Kimpp. 521-541KASL clinical practice guidelines for management of autoimmune hepatitis 2022The Korean Association for the Study of the Liver (KASL)pp. 542-592Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversityTakumi Kawaguchi, Tomotake Shirono, Hideki Iwamoto, Takashi Niizeki, Shigeo Shimosepp. 593-604Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infectionChih-Lin Lin, Jia-Horng Kaopp. 605-622Acute hepatitis C virus infection: clinical update and remaining challengesJia-Horng Kao, Chen-Hua Liupp. 623-642